The therapy, tested in mouse models, combines a delivery system that targets cancer cells with a specially modified version of microRNA-34a, a molecule that acts “like the brakes on a car,” slowing or stopping cell division, said Andrea Kasinski, lead author and the William and Patty Miller
Glioblastoma, the most prevalent and lethal type of brain cancer, spreads quickly, invading and destroying healthy brain tissue. The tumour shoots malignant tendrils into the brain, making surgical removal of the tumour extremely difficult or impossible.
The LINAC provides targeted laser-guided beam Radiotherapy, which specifically targets the cancer cells only and does not destroy the surrounding healthy tissue. This 360 degrees rotatory Radiotherapy machine can be used for treatment of any type for cancer.
In a ground-breaking development in the fight against myeloma, Israeli researchers developed a targeted procedure to effectively destroy cancer within the bone marrow.
A group of researchers led by Nanyang Technological University, Singapore (NTU Singapore) discovered that a cancer medicine that is currently on the market might be modified to target a subgroup of malignancies that are frequently linked with poor outcomes and lack focused therapy choices.
According to a recent Yale study, cancer cells with extra chromosomes depend on those chromosomes for tumour growth, and eliminating them prevents the cells from developing into tumours. The researchers' findings suggest that a unique strategy for treating cancer may involve selectively targ
A new Yale study found that cancer cells with extra chromosomes rely on those chromosomes for tumour formation, and eliminating them prevents the cells from developing tumours. The findings suggested the prospect of a revolutionary cancer therapy technique that selectively targets extra chro
A new study done by experts at The University of Texas MD Anderson Cancer Centre provides a deeper understanding of the development of the tumour microenvironment throughout the progression of gastric cancer. Two of the study's notable discoveries include a potential therapy target and a lin
Cancer cells with extra chromosomes rely on those chromosomes for tumour growth, according to a new Yale study, and removing them inhibits the cells from becoming tumours. According to the researchers, the findings show that specifically targeting additional chromosomes may offer a novel app
According to a recent Yale study, cancer cells with additional chromosomes rely on those chromosomes for tumour formation, and removing them stops the cells from growing tumours. The results, according to the researchers, point to the possibility of a novel cancer treatment strategy that spe
Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, but adding a second drug squelches the workaround. The study was published in Journal, 'Cell.'